In vitro cell-based toxicity testing of vaping and heated tobacco devices

This Request for Proposal (RFP) is split into two (2) streams. Stream 1: In vitro testing of vaping liquids and vaping liquid ingredients; and, Stream 2: In vitro air-liquid-interface testing of alternative product emissions. Work for each stream will be performed on an "as and when requested basis" using a Task Authorization (TA) process. Bidders must submit separate bids if bidding on both streams. Multiple contracts may be awarded in each Stream in order to meet requirements. For Stream 1, the Bidder must bid on Task A and at least one (1) Optional Task (B, C, D, E or F) and be compliant with all mandatory requirements in the RFP in order to be awarded a contract. For Stream 2, the Bidder must bid on Task 1 & 2 and be compliant with all mandatory requirements in the RFP in order to be awarded a contract. The services of the Contractor will be required for a period of approximately 12 months commencing on or about April 1st, 2019. The expected completion date of this project is the 31st of March, 2020. The Contract will be set up with the option of annual renewal up to a maximum of three (3) one (1) year renewals (option year 1: April 2020-March 2021; option year 2: April 2021-March 2022; option year 3: April 2022-March 2023) to be exercised at Health Canada’s discretion. Should option year(s) be exercised, the expected completion date for option year one is the 31st of March, 2021; option year two is the 31st of March, 2022; and option year three is the 31st of March, 2023. There are no security requirements associated with this requirement. The requirement is subject to the provisions of the World Trade Organization Agreement on Government Procurement (WTO-AGP), the North American Free Trade Agreement (NAFTA), the Canada-European Union Comprehensive Economic and Trade Agreement (CETA), and the Canadian Free Trade Agreement (CFTA) Stream 1: In vitro testing of vaping liquids and vaping liquid ingredients Health Canada requires the services of a Contractor to conduct in vitro toxicity testing of identified chemicals and vaping liquid samples in support of research activities at the Tobacco Control Directorate (TCD) on an "as and when requested basis" using a Task Authorization (TA) process. A minimum of one (1) Project Manager and one (1) Laboratory Technician are required. Work is to be completed at the Contractor’s place of business. Stream 2: In vitro air-liquid-interface testing of alternative product emissions Health Canada requires the services of a Contractor to conduct in vitro toxicity testing of emission from conventional or alternative devices at the air-liquid interface (ALI) in support of research activities at the Tobacco Control Directorate (TCD) on an "as and when requested basis" using a Task Authorization (TA) process. A minimum of one (1) Project Manager and one (1) Laboratory Technician are required. Work is to be completed at the Contractor’s place of business.